Septodont's Novocol Pharma secures $26M

2021 03 23 22 18 5645 Money Bag Grant Award 400

Septodont's Novocol Pharma division has secured $32.7 million Canadian ($26 million U.S.) from the Canadian government to further develop its injectable products.

The funding will increase biomanufacturing capability of fill-finish sterile injectables at Novocol Pharma's facility in Cambridge, Ontario, Septodont said.

Page 1 of 183
Next Page